12 Aug

Compulsory licensing of covid-19 treatments unlikely in China, Japan and South Korea

How five key Asian jurisdictions – China, India, Indonesia, Japan and South Korea – are likely to approach compulsory licensing during the coronavirus, according to practitioners based in each country

He Jing

Founder | GEN Law & Consulting

Lu Yong

Senior counsel | GEN Law & Consulting

Essenese Obhan

Founding partner | Obhan & Associates

New Delhi, India

Nick Redfearn

Deputy CEO | Rouse & Co International

Lisa Yong

Principal | Rouse

Toyotaka Abe

Partner | TMI Associates

Jeong Yeol Choe

Partner | Yulchon LLC

Kyung Ae Yoon

Senior patent attorney | Yulchon LLC

Cho Rong Yun

Associate | Yulchon LLC

Son Jin

Foreign attorney | Yulchon LLC